SUMMARY:
A former MiMedx employee has filed counterclaims against the company, alleging that MiMedx engaged in predatory sales practices and incentivized fraud, including Medicare fraud. The employee, Caralyn Gargan, left the company after becoming concerned about MiMedx's continued sales of a product that had not been approved by the FDA. The counterclaims come in response to MiMedx's lawsuit against 10 former employees, including Gargan, alleging breaches of contractual obligations.
PRESS RELEASE
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT (press release)
One of 10 defendants who were sued earlier this year by MiMedx Group, Inc. (NASDAQ: MDXG) today filed counterclaims against the placental biologics company. Caralyn Gargan, a former MiMedx employee, filed the action against MiMedx for “predatory sales practices” and “incentivized fraud, including Medicare fraud.” Gargan also formally presented her answers and defenses to MiMedx’s lawsuit which claimed that the 10 former employees, who recently left the company, allegedly breached their contractual obligations to MiMedx. The filing describes the MiMedx suit as a “blatant intimidation t...
